HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wen-Juei Jeng Selected Research

Patched-1 Receptor

2/2013High expression of patched homolog-1 messenger RNA and glioma-associated oncogene-1 messenger RNA of sonic hedgehog signaling pathway indicates a risk of postresection recurrence of hepatocellular carcinoma.
1/2013High expression of Sonic Hedgehog signaling pathway genes indicates a risk of recurrence of breast carcinoma.
1/2013Activation of the sonic hedgehog signaling pathway occurs in the CD133 positive cells of mouse liver cancer Hepa 1-6 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wen-Juei Jeng Research Topics

Disease

27Hepatocellular Carcinoma (Hepatoma)
10/2022 - 02/2005
26Chronic Hepatitis B
01/2022 - 06/2010
19Neoplasms (Cancer)
10/2022 - 02/2005
18Fibrosis (Cirrhosis)
01/2022 - 12/2013
10Infections
10/2022 - 12/2013
10Chronic Hepatitis C
10/2022 - 01/2012
9Hepatitis
01/2022 - 09/2011
6Hepatitis B
10/2022 - 05/2015
6Neoplasm Metastasis (Metastasis)
10/2019 - 02/2005
4Hemorrhage
02/2020 - 04/2011
4Glioma (Gliomas)
11/2019 - 01/2013
3End Stage Liver Disease
10/2019 - 12/2014
3Inflammation (Inflammations)
11/2017 - 12/2016
2Liver Diseases (Liver Disease)
02/2022 - 10/2021
2Liver Cirrhosis (Hepatic Cirrhosis)
10/2019 - 04/2015
2Necrosis
01/2016 - 09/2011
1Coinfection
10/2022
1Heart Diseases (Heart Disease)
02/2022
1Insulin Resistance
03/2021
1Ascites
02/2020
1Fever (Fevers)
01/2020
1Peritonitis
10/2019
1Hyperbilirubinemia
01/2018
1Hypoalbuminemia
09/2016
1Diabetes Mellitus
09/2016
1Lymphatic Metastasis
08/2016
1Adenocarcinoma of Lung
04/2016
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2016
1Colorectal Neoplasms (Colorectal Cancer)
10/2015
1Acute-On-Chronic Liver Failure
12/2014
1Adenocarcinoma
08/2014

Drug/Important Bio-Agent (IBA)

13Antiviral Agents (Antivirals)IBA
10/2022 - 06/2010
11Hepatitis B e AntigensIBA
01/2022 - 06/2010
11Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2022 - 03/2012
8Messenger RNA (mRNA)IBA
02/2013 - 02/2005
7Alanine Transaminase (SGPT)IBA
10/2022 - 12/2013
6entecavirFDA Link
01/2022 - 12/2013
6InterferonsIBA
08/2021 - 03/2011
5BilirubinIBA
03/2022 - 04/2015
5Tenofovir (Viread)FDA Link
01/2022 - 12/2016
5Cytidine Triphosphate (CTP)IBA
02/2020 - 12/2014
5Ribavirin (Virazole)FDA LinkGeneric
12/2019 - 03/2011
4Biomarkers (Surrogate Marker)IBA
10/2022 - 01/2013
4AlbuminsIBA
03/2022 - 09/2016
4DNA (Deoxyribonucleic Acid)IBA
01/2021 - 06/2010
3Sorafenib (BAY 43-9006)FDA Link
01/2022 - 01/2014
3Fetal Proteins (Fetoprotein)IBA
01/2017 - 01/2016
3Patched-1 ReceptorIBA
02/2013 - 01/2013
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
02/2022 - 01/2017
2HLA Antigens (Human Leukocyte Antigens)IBA
01/2022 - 12/2017
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2021 - 01/2020
2LigandsIBA
11/2019 - 08/2017
2Indicators and Reagents (Reagents)IBA
01/2019 - 09/2011
2Telomerase (Telomerase Reverse Transcriptase)IBA
11/2011 - 02/2005
1EnzymesIBA
02/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1lenvatinibIBA
01/2022
1nasIBA
08/2021
1AntigensIBA
11/2020
1Surface Antigens (Surface Antigen)IBA
11/2020
1Transcription Factors (Transcription Factor)IBA
11/2019
1MicroRNAs (MicroRNA)IBA
10/2019
1SodiumIBA
10/2019
1dasabuvirIBA
01/2018
1ombitasvirIBA
01/2018
1Cytochrome P-450 CYP2B1 (PROD)IBA
01/2018
1Ritonavir (Norvir)FDA Link
01/2018
1paritaprevirIBA
01/2018
1ChemokinesIBA
12/2017
1CytokinesIBA
12/2017
1HLA-DP Antigens (HLA-DP)IBA
12/2017
1HLA-DQ Antigens (HLA-DQ)IBA
12/2017
1Galectins (Galectin)IBA
11/2017
1Ephrin-A1 (Ephrin A1)IBA
08/2017
1CXC ChemokinesIBA
08/2017
1Transforming Growth Factors (Transforming Growth Factor)IBA
08/2017
1Hormones (Hormone)IBA
12/2016
1MucinsIBA
12/2016
1Epidermal Growth Factor (EGF)IBA
12/2016
1PlatinumIBA
04/2016
1Therapeutic UsesIBA
03/2016
1Type II Tumor Necrosis Factor ReceptorsIBA
10/2015
1Monoclonal AntibodiesIBA
10/2015
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2015
1HhAntag691IBA
09/2015
1Extracellular Matrix ProteinsIBA
06/2015
1Lamivudine (Epivir)FDA Link
05/2015
1EnbucrilateIBA
12/2014

Therapy/Procedure

32Therapeutics
01/2022 - 06/2008
4Radiofrequency Ablation
10/2022 - 03/2015
3Hepatectomy
11/2017 - 07/2013
2Tertiary Prevention
04/2021 - 12/2019
2Aftercare (After-Treatment)
01/2018 - 12/2014
2Adjuvant Chemotherapy
04/2016 - 08/2014
1Retreatment
12/2021
1Rejuvenation
08/2021
1Secondary Prevention
08/2019
1Operative Surgical Procedures
09/2016
1Lymph Node Excision (Lymph Node Dissection)
08/2016
1Immunotherapy
10/2015